Pay in 4 interest-free payments of $5.02 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
It is only accessible through participation in authorised clinical trials
This novel treatment, nearing Phase 1 clinical trials, could help prevent weight regain post-GLP-1 analogue use by mimicking the incretin hormone to suppress appetite and regulate blood sugar, thus aiding in the management of obesity and diabetes.
This means that initially, the drug concentration in the blood decreases rapidly, but then it takes a longer time to eliminate the remaining amount from the body
(2014) measured the hydrogen concentration in the tissues of rats that ingested hydrogen through different methods and found that oral and intraperitoneal injections can achieve higher hydrogen concentrations in multiple organs, while hydrogen inhalation results in elevated concentrations in muscle and brain tissues
US$ 22.40
US$ 29.31
US$ 23.25
